Akebia Therapeutics logo
Akebia Therapeutics AKBA
$ 0.39 -7.14%
report update icon

Quarterly report 2026-Q3
added 11-05-2026

Akebia Therapeutics Total Current Liabilities | AKBA

Annual Total Current Liabilities Akebia Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
163 M 80.9 M 99.9 M 130 M 261 M 187 M 208 M 266 M 144 M 114 M 11.9 M 6.88 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
266 M 6.88 M 139 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Annexon Annexon
ANNX
42.6 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
2.15 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
692 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.1 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
2.84 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
9.08 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
4.56 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
7.03 M - - $ 35.3 M usaUSA
Axcella Health Axcella Health
AXLA
14.1 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
7.76 M - - $ 24.2 M usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
250 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
21.4 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
42.7 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
1.32 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
6.85 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
122 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
2.74 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
49.6 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
17.6 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
2.47 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
9.94 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
10.8 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
6.63 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
82.4 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
321 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
6.25 M - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
17 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
20.8 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
7.5 M - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
20.1 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
85.1 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
11.8 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
48.8 M $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
47.1 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
26.9 M - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
64.1 M - - $ 58.1 M usaUSA